Tilray Brands, Inc. (TSX:TLRY)
13.18
-0.39 (-2.87%)
At close: Jan 16, 2026
Tilray Brands Revenue
Tilray Brands had revenue of $217.51M USD in the quarter ending November 30, 2025, with 3.11% growth. This brings the company's revenue in the last twelve months to $837.32M, up 0.98% year-over-year. In the fiscal year ending May 31, 2025, Tilray Brands had annual revenue of $821.31M with 4.10% growth.
Revenue (ttm)
$837.32M
Revenue Growth
+0.98%
P/S Ratio
1.31
Revenue / Employee
$294.62K
Employees
2,842
Market Cap
1.53B CAD
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 31, 2025 | 821.31M | 32.37M | 4.10% |
| May 31, 2024 | 788.94M | 161.82M | 25.80% |
| May 31, 2023 | 627.12M | -1.25M | -0.20% |
| May 31, 2022 | 628.37M | 115.29M | 22.47% |
| May 31, 2021 | 513.09M | 302.60M | 143.77% |
| Dec 31, 2020 | 210.48M | -194.84M | -48.07% |
| May 31, 2020 | 405.33M | 27.87M | 7.38% |
| Dec 31, 2019 | 377.46M | 198.16M | 110.52% |
| Jun 30, 2019 | 179.30M | 136.17M | 315.73% |
| Dec 31, 2018 | 43.13M | - | - |
| Jun 30, 2018 | 43.13M | 22.59M | 110.00% |
| Dec 31, 2017 | 20.54M | - | - |
| Jun 30, 2017 | 20.54M | 7.89M | 62.43% |
| Dec 31, 2016 | 12.64M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Curaleaf Holdings | 1.78B |
| dentalcorp Holdings | 1.66B |
| Trulieve Cannabis | 1.66B |
| Green Thumb Industries | 1.61B |
| Extendicare | 1.59B |
| WELL Health Technologies | 1.25B |
| Sienna Senior Living | 967.05M |
| DRI Healthcare Trust | 270.19M |
Tilray Brands News
- 1 day ago - 3 Canadian Marijuana Stocks For Investors In 2026 - MarijuanaStocks
- 3 days ago - What's Next for Tilray Brands After Posting Record Q2 Revenues? - Nasdaq
- 4 days ago - Should You Buy, Sell or Hold TLRY Stock Post Q2 Earnings? - Nasdaq
- 7 days ago - International Cannabis Expansion Gives Tilray Positive 2026 Outlook - Seeking Alpha
- 8 days ago - Tilray Valuation Attractive With Strong Growth Overseas, Analyst Says - Benzinga
- 8 days ago - Tilray Stock Couldn’t Sustain Its Trump Gains. How Cannabis Earnings Could Help. - Barron's
- 8 days ago - These Stocks Are Moving the Most Today: Oklo, Vistra, Opendoor, Intel, GM, Revolution Medicines, Tilray, and More - Barron's
- 8 days ago - Marijuana industry taking fight against Wall Street blockades straight to Trump - New York Post